Half-year report · HY
4202.TEDINET S100WZR6
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥277.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥586.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥289.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥20.1bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥31.6bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥20.4bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥62.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥30.7bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥26.2bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥41.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥18.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥49.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥32.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥19.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥32.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥848.9bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥813.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥827.8bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥454.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥438.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥394.2bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥375.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥392.3bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥64.7bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥65.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥64.4bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥68.4bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥32.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥93.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥50.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥26.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥47.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥29.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥7.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥48.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥24.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥70.9 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.44 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.18 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.7% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 65
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥9.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥7.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥400m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥13.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥13.4bn |
| Engineering Plasticsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥122.0bn |
| Engineering Plasticsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥121.9bn |
| Engineering Plasticsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥106m |
| Engineering Plasticsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥11.5bn |
| Materialsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥83.1bn |
| Materialsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥77.2bn |
| Materialsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5.9bn |
| Materialsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Medical Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥7.6bn |
| Medical Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥7.6bn |
| Medical Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥208m |
| Safetyreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥49.7bn |
| Safetyreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥49.7bn |
| Safetyreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.7bn |
| Smartreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥18.2bn |
| Smartreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥18.2bn |
| Smartreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥67m |
| Smartreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥404m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥280.7bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥274.6bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥6.1bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥19.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥290.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥277.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥20.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥9.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥344m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥13.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥13.8bn |
| Engineering Plasticsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥124.6bn |
| Engineering Plasticsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥124.5bn |
| Engineering Plasticsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥96m |
| Engineering Plasticsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥15.2bn |
| Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥95.1bn |
| Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥88.5bn |
| Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.3bn |
| Medical Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥7.2bn |
| Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥7.2bn |
| Medical Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥189m |
| Safetyreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥47.1bn |
| Safetyreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥47.1bn |
| Safetyreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Smartreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥19.6bn |
| Smartreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥19.6bn |
| Smartreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥51m |
| Smartreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥215m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥293.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥286.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥31.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥303.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥289.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥31.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 588
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 7318000000 | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 13382000000 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -13382000000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E00818-000MedicalHealthcareReportableSegmentMember | 7634000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E00818-000SmartReportableSegmentMember | 18239000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E00818-000SafetyReportableSegmentMember | 49723000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E00818-000MaterialsReportableSegmentMember | 83056000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E00818-000EngineeringPlasticsReportableSegmentMember | 122022000000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 280674000000 | JPY |
| Net sales | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 9827000000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 290501000000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | -13382000000 | JPY |
| Net sales | InterimDuration | 277119000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E00818-000MedicalHealthcareReportableSegmentMember | 208000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E00818-000SmartReportableSegmentMember | 404000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E00818-000SafetyReportableSegmentMember | 2663000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E00818-000MaterialsReportableSegmentMember | 4974000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E00818-000EngineeringPlasticsReportableSegmentMember | 11470000000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | 19720000000 | JPY |
| Operating income | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 400000000 | JPY |
| Operating income | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 20121000000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | － | JPY |
| Operating income | InterimDuration | 20121000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-10 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第160期中(自 2025年４月１日 至 2025年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ダイセル | |
| Company name in english cover page | FilingDateInstant | Daicel Corporation | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 榊 康裕 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市北区大深町３番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)(06)7639－7171(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)事業支援本部経理グループリーダー 髙橋 清 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区港南二丁目18番１号 東京本社事務所 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | (03)6711－8121 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員 事業支援本部副本部長(兼)事業支援本部ＩＲ広報グループリーダー 廣川 正彦 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00818 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 42020 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ダイセル | |
| Filer name in english | FilingDateInstant | Daicel Corporation | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |